Online Only Articles

Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma)

Department of Haematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Germany;Comprehensive Cancer Center Freiburg (CCCF), Faculty of Medicine, University of Freiburg, Germany
Department of Haematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Germany;Comprehensive Cancer Center Freiburg (CCCF), Faculty of Medicine, University of Freiburg, Germany
Clinical Trials Unit, Faculty of Medicine, University of Freiburg, Germany
Clinical Trials Unit, Faculty of Medicine, University of Freiburg, Germany
Department of Haematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Germany
Department of Haematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Germany
Institute of Pathology, Faculty of Medicine, University of Freiburg, Germany
Institute of Pharmaceutical Sciences, Faculty of Medicine, University of Freiburg, Germany
Institute of Pharmaceutical Sciences, Faculty of Medicine, University of Freiburg, Germany
Institute of Pathology, Faculty of Medicine, University of Freiburg, Germany
Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy
Department of Haematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Germany;Comprehensive Cancer Center Freiburg (CCCF), Faculty of Medicine, University of Freiburg, Germany
Institute of Pharmaceutical Sciences, Faculty of Medicine, University of Freiburg, Germany
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA
Department of Haematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Germany;Comprehensive Cancer Center Freiburg (CCCF), Faculty of Medicine, University of Freiburg, Germany
Department of Haematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Germany;Comprehensive Cancer Center Freiburg (CCCF), Faculty of Medicine, University of Freiburg, Germany
Vol. 103 No. 10 (2018): October, 2018 https://doi.org/10.3324/haematol.2018.189969